rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2000-2-15
|
pubmed:abstractText |
Chronic myelogenous leukemia (CML) is a clonal myeloproliferative disorder resulting from the neoplastic transformation of a hematopoietic stem cell. The majority of cases of CML are associated with the (9;22) chromosome translocation that generates the bcr-abl chimeric gene. Alpha interferon (IFN-alpha) treatment induces hematological remission and prolongs life in 75% of CML patients in the chronic phase. It has been shown that mice deficient in interferon consensus sequence binding protein (ICSBP), a member of the interferon regulatory factor family, manifest a CML-like syndrome. We have shown that expression of Bcr-Abl in bone marrow (BM) cells from 5-fluorouracil (5-FU)-treated mice by retroviral transduction efficiently induces a myeloproliferative disease in mice resembling human CML. To directly test whether icsbp can function as a tumor suppressor gene, we examined the effect of ICSBP on Bcr-Abl-induced CML-like disease using this murine model for CML. We found that expression of the ICSBP protein was significantly decreased in Bcr-Abl-induced CML-like disease. Forced coexpression of ICSBP inhibited the Bcr-Abl-induced colony formation of BM cells from 5-FU-treated mice in vitro and Bcr-Abl-induced CML-like disease in vivo. Interestingly, coexpression of ICSBP and Bcr-Abl induced a transient B-lymphoproliferative disorder in the murine model of Bcr-Abl-induced CML-like disease. Overexpression of ICSBP consistently promotes rather than inhibits Bcr-Abl-induced B lymphoproliferation in a murine model where BM cells from non-5-FU-treated donors were used, indicating that ICSBP has a specific antitumor activity toward myeloid neoplasms. We also found that overexpression of ICSBP negatively regulated normal hematopoiesis. These data provide direct evidence that ICSBP can act as a tumor suppressor that regulates normal and neoplastic proliferation of hematopoietic cells.
|
pubmed:grant |
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/10648600-10224280,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10648600-10490629,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10648600-1460054,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10648600-1691092,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10648600-1730873,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10648600-178822,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10648600-2111015,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10648600-2179728,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10648600-2204061,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10648600-2406902,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10648600-3047582,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10648600-4318922,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10648600-7518835,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10648600-7526889,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10648600-7537982,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10648600-7678054,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10648600-7690960,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10648600-7797077,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10648600-7926767,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10648600-7992097,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10648600-8133040,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10648600-8197182,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10648600-8479746,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10648600-8541551,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10648600-8621906,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10648600-8839828,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10648600-8861914,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10648600-8951783,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10648600-8958917,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10648600-9028327,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10648600-9092512,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10648600-9348310,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10648600-9348311,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10648600-9414265,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10648600-9474745,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10648600-9490692,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10648600-9593745,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10648600-9635566,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10648600-9808572,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10648600-9808576,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10648600-9865486,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10648600-9916702
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0270-7306
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
20
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1149-61
|
pubmed:dateRevised |
2009-11-18
|
pubmed:meshHeading |
pubmed-meshheading:10648600-Humans,
pubmed-meshheading:10648600-Animals,
pubmed-meshheading:10648600-Mice,
pubmed-meshheading:10648600-Male,
pubmed-meshheading:10648600-Bone Marrow Transplantation,
pubmed-meshheading:10648600-Hematopoiesis,
pubmed-meshheading:10648600-Base Sequence,
pubmed-meshheading:10648600-Disease Models, Animal,
pubmed-meshheading:10648600-Interferons,
pubmed-meshheading:10648600-Fluorouracil,
pubmed-meshheading:10648600-Myeloproliferative Disorders,
pubmed-meshheading:10648600-Antimetabolites, Antineoplastic,
pubmed-meshheading:10648600-Leukemia, Myelogenous, Chronic, BCR-ABL Positive,
pubmed-meshheading:10648600-Mice, Inbred BALB C,
pubmed-meshheading:10648600-Translocation, Genetic,
pubmed-meshheading:10648600-Lymphoproliferative Disorders,
pubmed-meshheading:10648600-Repressor Proteins,
pubmed-meshheading:10648600-B-Lymphocytes,
pubmed-meshheading:10648600-Down-Regulation,
pubmed-meshheading:10648600-Colony-Forming Units Assay,
pubmed-meshheading:10648600-DNA Primers,
pubmed-meshheading:10648600-Consensus Sequence
|